MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 23, 2005; DOI: 10.1124/mol.105.018093


0026-895X/06/6903-846-856$20.00
Mol Pharmacol 69:846-856, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.105.018093v1
69/3/846    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, C.-C.
Right arrow Articles by Hsu, K.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, C.-C.
Right arrow Articles by Hsu, K.-S.

Presynaptic Mechanism Underlying cAMP-Induced Synaptic Potentiation in Medial Prefrontal Cortex Pyramidal NeuronsFormula

Chiung-Chun Huang, and Kuei-Sen Hsu

Department of Pharmacology, College of Medicine, and Center for Gene Regulation and Signal Transduction Research, National Cheng Kung University, Tainan, Taiwan

cAMP, a classic second messenger, has been proposed recently to participate in regulating prefrontal cortical cognitive functions, yet little is known about how it does so. In this study, we used forskolin, an adenylyl cyclase activator, to examine the effects of cAMP on excitatory synaptic transmission in the medial prefrontal cortex (mPFC) using whole-cell patch-clamp recordings from visually identified layer II-III or V pyramidal cells in vitro. We found that bath application of forskolin significantly increased the amplitude of excitatory postsynaptic currents (EPSCs) in a concentration- and age-dependent manner. This enhancement was completely abolished by coapplication of cAMP-dependent protein kinase (PKA) inhibitor and p42/p44 mitogen-activated protein kinase (MAPK) kinase inhibitor, but not application of either drug alone. The membrane-permeable cAMP analog adenosine 3',5'-cyclic monophosphorothioate, Sp-isomer, triethylammonium salt, or activation of beta-adrenergic receptor by isoproterenol mimicked the effect of forskolin to potentiate EPSCs. However, neither exchange protein activated by cAMP (Epac) inhibitor brefeldin A nor hyperpolarization and cyclic nucleotide-activated channel blocker 4-ethylphenylamino-1,2-dimethyl-6-methylaminopyrimidinium chloride (ZD7288) affected forskolin response. The augmentation of EPSCs by forskolin was accompanied by a reduction of the synaptic failure rate, coefficient of variation and paired-pulse ratio of EPSCs, and an increase in release probability and number of releasable synaptic vesicles. Forskolin also significantly increased the frequency of miniature EPSCs without altering their amplitude distribution. These results indicate that cAMP acts presynaptically to elicit a synaptic potentiation on the layer V pyramidal neurons of mPFC through converging activation of PKA and p42/p44 MAPK signaling pathways.


Received August 16, 2005; accepted November 23, 2005

Address correspondence to: Dr. Kuei-Sen Hsu, Department of Pharmacology, College of Medicine, National Cheng Kung University, 1, University Rd., Tainan City 701, Taiwan. E-mail:richard{at}mail.ncku.edu.tw




This article has been cited by other articles:


Home page
J. Neurosci.Home page
I. Gekel and E. Neher
Application of an Epac Activator Enhances Neurotransmitter Release at Excitatory Central Synapses
J. Neurosci., August 6, 2008; 28(32): 7991 - 8002.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
X.-H. Ji, X.-H. Cao, C.-L. Zhang, Z.-J. Feng, X.-H. Zhang, L. Ma, and B.-M. Li
Pre- and Postsynaptic {beta}-Adrenergic Activation Enhances Excitatory Synaptic Transmission in Layer V/VI Pyramidal Neurons of the Medial Prefrontal Cortex of Rats
Cereb Cortex, July 1, 2008; 18(7): 1506 - 1520.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
T. J. Searl and E. M. Silinsky
Mechanisms of Neuromodulation as Dissected Using Sr2+ at Motor Nerve Endings
J Neurophysiol, June 1, 2008; 99(6): 2779 - 2788.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. S. O'Neill, E. S. Maywood, J. E. Chesham, J. S. Takahashi, and M. H. Hastings
cAMP-Dependent Signaling as a Core Component of the Mammalian Circadian Pacemaker
Science, May 16, 2008; 320(5878): 949 - 953.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. L. Moulder, X. Jiang, C. Chang, A. A. Taylor, A. M. Benz, A. C. Conti, L. J. Muglia, and S. Mennerick
A Specific Role for Ca2+-Dependent Adenylyl Cyclases in Recovery from Adaptive Presynaptic Silencing
J. Neurosci., May 14, 2008; 28(20): 5159 - 5168.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
K. B. Grey and B. D. Burrell
Forskolin Induces NMDA Receptor-Dependent Potentiation at a Central Synapse in the Leech
J Neurophysiol, May 1, 2008; 99(5): 2719 - 2724.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. Wang, Y. Gu, G.-W. Li, and L.-Y. M. Huang
A critical role of the cAMP sensor Epac in switching protein kinase signalling in prostaglandin E2-induced potentiation of P2X3 receptor currents in inflamed rats
J. Physiol., October 1, 2007; 584(1): 191 - 203.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
C.-C. Huang, H.-J. Lin, and K.-S. Hsu
Repeated Cocaine Administration Promotes Long-Term Potentiation Induction in Rat Medial Prefrontal Cortex
Cereb Cortex, August 1, 2007; 17(8): 1877 - 1888.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C.-C. Huang, P.-C. Yang, H.-J. Lin, and K.-S. Hsu
Repeated Cocaine Administration Impairs Group II Metabotropic Glutamate Receptor-Mediated Long-Term Depression in Rat Medial Prefrontal Cortex
J. Neurosci., March 14, 2007; 27(11): 2958 - 2968.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics